Osiris Therapeutics Inc (OSIR.OQ) Quote| Reuters.com
Edition:
United States

Osiris Therapeutics Inc (OSIR.OQ)

OSIR.OQ on NASDAQ Stock Exchange Global Market

5.35USD
12:33pm EDT
Change (% chg)

$0.20 (+3.88%)
Prev Close
$5.15
Open
$5.21
Day's High
$5.45
Day's Low
$5.20
Volume
12,097
Avg. Vol
53,393
52-wk High
$23.32
52-wk Low
$3.55

OSIR.OQ

Chart for OSIR.OQ

About

Osiris Therapeutics, Inc. is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company's offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and... (more)

Overall

Beta: 0.73
Market Cap(Mil.): $177.43
Shares Outstanding(Mil.): 34.45
Dividend: 0.20
Yield (%): --

Financials

  OSIR.OQ Industry Sector
P/E (TTM): 104.55 38.36 34.67
EPS (TTM): 0.05 -- --
ROI: 2.06 -6.77 14.11
ROE: 2.10 -6.10 15.33

BRIEF-Mimedx Group files lawsuit against Osiris for false and misleading representations

* Says files lawsuit against Osiris for false and misleading representations

May 17 2016

BRIEF-Osiris provides update regarding Nasdaq listing matters

* Osiris provides update regarding Nasdaq listing matters Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 16 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.